1201 SGN-BB228 is a first-in-class CD228-targeted costimulatory antibody anticalin®bispecific delivering potent and conditional 4–1BB costimulation to tumor-specific T cells
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.